Decision Aid for Gender Dysphoria

Recruiting in Palo Alto (17 mi)

+1 other location

Overseen byRachel A. Moses, MD, MPH

Age: 18+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Dartmouth-Hitchcock Medical Center

No Placebo Group

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to test a new online tool designed to provide clear and understandable information to help individuals considering Metoidioplasty and Phalloplasty Gender Affirming Surgery (MaPGAS)make informed decisions The main questions it aims to answer are: * How user-friendly is the decision aid for individuals considering metoidioplasty and phalloplasty? * Does using the decision aid reduce uncertainty and improve readiness for making surgery decisions compared to usual care? Participants in this study will: * Be randomly assigned to either 1) receive usual care or 2) test the web-based decision aid. * Share their feedback on the tool's usability and its helpfulness in supporting decision-making. * Complete surveys before and after using the decision aid to measure any changes in their decision-making process. Researchers will compare participants who used the decision aid with those who received standard care to see if the decision aid reduces decisional uncertainty and improves readiness for surgery.

Eligibility Criteria

This trial is for transgender individuals considering gender-affirming surgeries, specifically metoidioplasty and phalloplasty. Participants should be in the decision-making process regarding these surgeries and willing to provide feedback on a new online decision aid tool.

Inclusion Criteria

I identify as a transgender male or gender non-binary.

Able to speak, read, and understand English at a sixth-grade level

Resides in the USA

See 4 more

Exclusion Criteria

Participants involved in the initial tool refinement focus groups cannot participate in the intervention or control group to avoid contamination of the study outcomes.

Treatment Details

Interventions

MaPGAS Decision Aid (Behavioral Intervention)

Trial OverviewThe study tests an online tool designed to help with decisions about Metoidioplasty and Phalloplasty Gender Affirming Surgery (MaPGAS). It compares the experiences of those using this tool against those receiving standard care, focusing on user-friendliness and its impact on surgery readiness.

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: MaPGAS Decision Aid InterventionExperimental Treatment1 Intervention

Participants in this arm will be provided with access to a novel, web-based decision aid designed for individuals considering MaPGAS. The decision aid includes interactive components, educational materials regarding surgical options, risks, benefits, and patient testimonials. Participants will have unlimited access to the decision aid for four weeks prior to their surgical consultation.

Group II: MaPGAS Usual CareActive Control1 Intervention

Participants in this arm will receive the standard pre-consultation care provided by their healthcare provider, which does not include access to the novel decision aid. Standard care may include informational brochures. This group serves to compare the outcomes of traditional decision-making processes with those who use the decision aid.